The pharma giant is facing stiff competition that is hurting sales of its weight loss and diabetes treatments.
*Stock prices used were the afternoon prices of Aug. 3, 2025. The video was published on Aug. 5, 2025.

Competition is hurting sales of critical products.
The pharma giant is facing stiff competition that is hurting sales of its weight loss and diabetes treatments.
*Stock prices used were the afternoon prices of Aug. 3, 2025. The video was published on Aug. 5, 2025.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.